“…Expression of GAP-43, and SLC18A3 cells were unchanged between control and NSC-34/hPGRN cells but were decreased in NSC-34/shPGRN, Note the presence of genes associated with neurotransmission, cytoskeletal organization, and congenital neurological disorders. Among genes that showed the greatest fold down-regulation in NSC-34/shPGRN cells compared to NSC-34/hPGRN cells were several associated with neurotransmission (dopamine decarboxylase, vesicular GABA transporter, alpha-2 adrenergic receptor) (Azzouz et al, 2002;Bucheler et al, 2002;Johnson et al, 2003), cytoskeletal organization (Stathmin 2, FGD2, SRGAP3) (Endris et al, 2002;Budhachandra et al, 2008;Hayakawa et al, 2008;Carlson et al, 2011;Klim et al, 2019) and RNA-binding proteins with roles in neuron development, survival, or congenital motor disorders (IGF2BP1, TSHZ1, GLE1) (Nousiainen et al, 2008;Gaynes et al, 2015;Zhang et al, 2018;Chaimowicz et al, 2019). further supporting a role for PGRN in supporting neuronlike structural differentiation in NSC-34 cells.…”